To determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses in groups 3-5, as well as other rapidly emerging viruses that utilize the same assay…
Ended Awarded Last action
- Contract number
- 75N93023F00004
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $277,692
Award facts
- Contract value 64% obligated
-
- $277,692.00 Current, with exercised options
- $431,621.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Logan, UT 84322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $6,237 | |
| Original award | $271,455 |
About this award
Utah State University has been awarded a delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite delivery contract held by the National Institute of Allergy and Infectious Diseases. This $431,621 firm fixed price order tasks Utah State University to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses in Groups 3-5, as well as other rapidly emerging viruses that utilize the same assay methodology. Performance will take place in Logan, Utah through September 2024. No set-aside designation was applied to this award made under the National Institutes of Health's program to assess antimicrobial activity against priority pathogens through in vitro testing services.
Description
To determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses in groups 3-5, as well as other rapidly emerging viruses that utilize the same assay methodology.
Quick answers
Who was awarded contract 75N93023F00004?
75N93023F00004 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 5, 2023.
How much is contract 75N93023F00004 worth?
The government has obligated $277,692 on 75N93023F00004. Its potential value, with all options, is $431,621.
Is contract 75N93023F00004 an order under another contract?
Yes. 75N93023F00004 is a delivery order under 75N93019D00021, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93023F00004 competed?
The extent of competition for 75N93023F00004 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award